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Primary care
Association between falls in elderly women and chronic
diseases and drug use: cross sectional study
Debbie A Lawlor, Rita Patel, Shah Ebrahim
Abstract
Objective To assess the associations between having
had a fall and chronic diseases and drug use in elderly
women.
Design Cross sectional survey, using data from the
British women’s heart and health study.
Setting General practices in 23 towns in Great
Britain.
Participants 4050 women aged 60-79 years.
Main outcome measure Whether women had had
falls in the previous 12 months.
Results The prevalence of falling increased with
increasing numbers of simultaneously occurring
chronic diseases. However, no such relation with
falling was found in the fully adjusted data for the
number of drugs used. Circulatory disease, chronic
obstructive pulmonary disease, depression, and
arthritis were all associated with an increased odds of
falling. The fully adjusted, population attributable risk
of falling associated with having at least one chronic
disease was 32.2% (95% confidence interval 19.6% to
42.8%). Only two classes of drugs (hypnotics and
anxiolytics, and antidepressants) were independently
associated with an increased odds of falling. Each class
was associated with an increase of about 50% in the
odds of falling, and each had a population attributable
risk of < 5%.
Conclusion Chronic diseases and multiple pathology
are more important predictors of falling than
polypharmacy.
Introduction
Falls among elderly people are common and are asso-
ciated with increased morbidity, disability, social isola-
tion, and a lower quality of life and with early entry
into residential care in this group.1 A number of
chronic diseases are associated with a higher risk of
falling, as are several classes of drugs, particularly
tranquillisers and antidepressants.1-3 However, few
studies have assessed the independent associations of
a range of risk factors in a single study group. We
aimed to assess the independent associations of
chronic diseases and drug use and the risk of falls in a
group of women aged 60-79 years and living in the
community.
Methods
Participants
The women were participants in the British women’s
heart and health study. Full details of the selection of
participants and measurements taken have been
reported in previous studies.4-6 We used the British
regional heart study framework to randomly select
women aged 60-79 from general practice lists in 23
towns in England, Scotland, and Wales. No women
were excluded from the study, and all 7166 women in
the age range, regardless of whether they normally
lived in private accommodation, a residential home, or
a nursing home, and irrespective of medical
conditions, were invited to participate. Transport to
examination centres was offered to immobile and frail
women. Invitations were sent to the women, and two
reminders were sent to non-responders. A total of
4286 women (60% of those invited) participated.
Baseline data (from a self completed questionnaire,
interviews by a research nurse, physical examination,
and review of primary care medical records) were
collected between April 1999 and March 2001.
Assessment of falls
In the self completed questionnaire participants were
asked whether they had had a fall in the previous 12
months, how many times they had fallen, and whether
they had received medical attention for any falls. No
specific definition of a fall was given in these questions.
As in other studies, we defined frequent falling as at
least two falls in the previous 12 months.7
Assessment of chronic diseases
We collated details of clinical diagnoses of each of the
women’s chronic diseases, together with the dates of
first diagnosis, from a combination of review of
primary care medical records, interviews by a research
nurse, and the participants’ responses to the
questionnaire.4-6 Coronary heart disease was defined as
any previous diagnosis of myocardial infarction or
angina. Circulatory disease was defined as any diagno-
sis of myocardial infarction, angina, stroke, transient
ischaemic attack, aortic artery disease, or peripheral
artery disease. Chronic obstructive pulmonary disease
included asthma and chronic bronchitis, and eye
disease included cataracts and glaucoma.
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Assessment of current drug use
Participants were asked to bring all their current medi-
cines to the clinic visit, and at the research nurse’s
interview a full drug history was taken. Drugs were
coded according to the British National Formulary: hyp-
notics and anxiolytics (drugs in section 4.1); antide-
pressants (4.3); any central nervous system drugs (4.1
to 4.11); analgesics (4.7 and 10.1.1); cardiovascular sys-
tem drugs (2.1 to 2.12); endocrine system drugs (6.1 to
6.7); and respiratory system drugs (3.1 to 3.3).8 In ana-
lysing the data on analgesic drugs we did a sensitivity
analysis in which non-steroidal anti-inflammatory
drugs were not included in the definition (only drugs
in section 4.7 were included). The results of this sensi-
tivity analysis did not differ significantly from the
results presented here.
Other measurements
We measured blood pressure with a Dinamap 1846SX
vital signs monitor (GE Clinical Services, Northamp-
ton).We took two measurements in succession, with a 1
minute interval, on the right arm, with the participant
seated and the arm supported on a cushion at chest
level. Participants were then asked to stand, with their
arms relaxed and at their sides, and two standing
measurements were taken. The mean of the two meas-
urements was used in all analyses. Postural hypoten-
sion was defined as a reduction between sitting and
standing of ≥ 20 mm Hg in systolic blood pressure or
≥ 10 mm Hg in diastolic pressure.9 We also assessed
the association of low standing blood pressure (systolic
≤ 100 mm Hg or diastolic ≤ 60 mm Hg) with falls.
We derived two measures of alcohol consumption
from the questionnaire data: regular daily consump-
tion (or consumption on most days) of any alcohol;
and heavy drinking, defined as ≥ 14 units of alcohol a
week. Social class was derived, in the case of married
women, from the longest held occupation of the
husband or, in single women, from her own longest
held occupation. Social class was defined according to
the registrar general’s classification.
Statistical analysis
We used multiple logistic regression to assess
associations with falls. Of the 4286 women who partici-
pated 425 could not be assigned an adult social class.
These women were likely to have been married to
unemployed men, and as their risk factor profiles were
similar to those of women in social class V they were
allocated to this group, as in previous analyses.5 Sensi-
tivity analyses in which these women were excluded
showed no significant difference in the findings. There
were a few missing data for each of the other variables,
and the multivariable analyses were conducted on the
3742 women (92%) with complete data on all the vari-
ables that were included in the final fully adjusted
Table 1 Characteristics of women who had had no fall or at least one fall in the previous 12 months. Values are percentage of
women (95% confidence interval), adjusted for age, except where otherwise indicated
No falls (n=3364) At least one fall (n=686) P value
Mean age (years) 68.6 (68.4 to 68.9) 70.1 (69.7 to 70.5) <0.001
Chronic diseases
Coronary heart disease 14.0 (12.9 to 15.2) 23.3 (20.3 to 26.6) <0.001
Any circulatory disease 16.8 (15.5 to 18.1) 26.7 (23.5 to 30.1) <0.001
Diabetes 4.9 (4.3 to 5.7) 6.9 (5.2 to 9.0) 0.04
Thyroid disease 11.4 (10.3 to 12.5) 14.2 (11.8 to 17.3) 0.04
Chronic obstructive pulmonary disease 22.6 (21.2 to 24.0) 30.8 (27.4 to 34.3) <0.001
Depression 15.8 (14.5 to 17.1) 27.0 (23.6 to 30.6) <0.001
Eye disease 13.9 (12.8 to 15.1) 19.9 (17.0 to 23.0) <0.001
Arthritis 41.7 (40.0 to 43.3) 58.2 (54.5 to 61.9) <0.001
Postural hypotension* 17.1 (15.8 to 18.5) 17.6 (14.8 to 20.9) 0.75
Low standing blood pressure† 7.6 (6.7 to 8.6) 7.3 (5.5 to 9.7) 0.81
Drugs taken
Hypnotics and anxiolytics 4.3 (3.7 to 5.1) 8.6 (6.7 to 10.9) <0.001
Antidepressants 9.0 (8.1 to 10.0) 17.1 (14.4 to 20.1) <0.001
Any central nervous system drug 23.5 (22.1 to 25.0) 36.9 (33.3 to 40.6) <0.001
Any analgesic 12.6 (11.6 to 13.8) 18.1 (15.4 to 21.1) <0.001
Any cardiovascular disease drug 40.9 (39.3 to 42.6) 50.4 (46.7 to 54.2) <0.001
Any endocrine system drug 19.9 (18.5 to 21.2) 21.4 (18.5 to 24.7) 0.25
Any respiratory system drug 10.2 (9.2 to 11.2) 13.1 (10.8 to 15.9) 0.03
Socioeconomic position
Manual social class (III manual, IV, or V) 52.0 (50.2 to 53.7) 55.3 (51.4 to 59.1) 0.12
From deprived area 19.3 (18.0 to 20.6) 20.1 (17.3 to 23.3) 0.61
Physiological and behavioural characteristics
Consume alcohol daily 17.5 (16.1 to 18.8) 17.5 (14.8 to 20.5) 0.80
Heavy drinking (≥ 14 units alcohol a week) 5.5 (4.8 to 6.3) 6.0 (4.4 to 8.0) 0.39
Mean body mass index (kg/m2) 27.4 (27.2 to 27.6) 28.4 (28.0 to 28.8) <0.001
Mean HDL cholesterol concentration (mmol/l) 1.66 (1.65 to 1.68) 1.64 (1.60 to 1.67) 0.22
Triglyceride concentration (geometric mean) (mmol/l) 1.66 (1.63 to 1.68) 1.68 (1.62 to 1.74) 0.41
Hypertension‡ 50.6 (48.7 to 52.4) 51.6 (47.5 to 55.6) 0.39
Mean forced expiratory volume in 1 second (l) 1.99 (1.97 to 2.00) 1.94 (1.90 to 1.99) 0.02
Mean haemoglobin concentration (g/l) 135.4 (135.0 to 135.8) 133.9 (133.1 to 134.8) 0.002
Hip or wrist fracture in previous 12 months 0.2 (0.1 to 0.4) 6.8 (5.1 to 8.9) <0.001
*Reduction in blood pressure between standing and sitting of ≥20 mm Hg systolic pressure or ≥10 mm Hg diastolic pressure.
†Systolic blood pressure ≤100 mm Hg or diastolic blood pressure ≤60 mm Hg.
‡Blood pressure >160/95 mm Hg or patient taking treatment for blood pressure.
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model. These 3742 women did not differ from the
women without complete data in age or in the
prevalence of any falls, frequent falls, or falls where the
women received medical attention (P > 0.4 for all vari-
ables). We estimated population attributable risks of
falling for risk factors from the fully adjusted logistic
regression models, using maximum likelihood esti-
mates as proposed by Greenland and Drescher.10 In all
analyses we used robust standard errors, which take
into account the clustering effects in each town, to cal-
culate 95% confidence intervals. We used Stata version
8.0 (StataCorp, College Station, TX, 2002) for all statis-
tical analyses.
Results
Of the 4286 participants 4050 (94%) provided data on
falls. There were no differences between the women
who provided these data and the other women in age,
prevalence of any chronic diseases, drug use, or socio-
economic position (P > 0.15 for all variables). Of the
4050 women 686 had fallen at least once in the previ-
ous 12 months, giving a prevalence of 16.9% (95%
confidence interval 15.8% to 18.1%). The prevalence of
frequent falling was 7.0% (6.2% to 7.8%) and of falls
where medical attention was given was 6.8% (6.0% to
7.6%).
Women who had fallen at least once in the previous
12 months were older than women who had not fallen
and were more likely to have chronic diseases, more
likely to be taking drugs, and had a higher body mass
index (table 1). Postural hypotension and low standing
blood pressure were not associated with falling. The
women who had fallen had a lower mean haemoglobin
concentration, and this inverse association remained
even when data were adjusted for social class, body
mass index, chronic diseases, and each class of drug
used. The fully adjusted odds ratio of any falls for an
increase in haemoglobin concentration of one
standard deviation was 0.90 (0.81 to 0.99). Very few of
the women had anaemia: no women had a haemo-
globin concentration below 80 g/l, 15 had a
concentration below 100 g/l, and 222 (5.5%) had a
concentration below 120 g/l. Alcohol consumption
was not related to falling. In the 12 months before the
women’s baseline examination 55 women (1.28%) had
had a fractured hip (15 women) or wrist (44 women).
Women who had had a fall in the previous 12 months
were much more likely to have had a fracture than the
women who hadn’t had a fall (table 1).
Drug use and falls
Just over 70% (2887) of the women were taking at least
one drug, and 622 (15.4%) were taking five or more
drugs. There was a strong linear association between
the number of drugs that women took and whether
they had had a fall (figure). However, the association
was not significant when the data were adjusted for
chronic diseases and other potential confounding fac-
tors. The crude odds ratio for a fall in the previous 12
months for each additional drug taken was 1.14 (1.10
to 1.19), but the fully adjusted odds ratio was 1.01 (0.96
to 1.06). Linear associations between frequent falls and
falls receiving medical attention and the number of
drugs taken were similar, with the fully adjusted models
showing no significant associations. Use of hypnotics
or anxiolytics and use of antidepressants were
associated with an increased odds of falling, even with
adjustment for chronic disease status (including ever
having had a diagnosis of depression) and other
potential confounding factors (table 2). In the fully
adjusted analyses analgesics, cardiovascular system
drugs, endocrine system drugs, and respiratory disease
drugs were not independently associated with having
had a fall (table 2).
Chronic disease and falls
Nearly three quarters (2961) of the women had at least
one chronic disease. There was a marked linear trend
of increasing odds of falling with increasing number of
chronic diseases (figure). This association remained
even after adjustment for drug use and other potential
confounding factors. The crude odds ratio for any fall
in the previous 12 months for each additional simulta-
neously occurring disease was 1.46 (1.36 to 1.56), and
the fully adjusted odds ratio was 1.37 (1.25 to 1.49). We
found similar linear trends for the association between
increasing numbers of simultaneously occurring
chronic diseases and frequent falls and treated falls,
and these associations remained significant in the fully
adjusted models.
Circulatory disease, chronic obstructive pulmonary
disease, depression, and arthritis were each associated
with a higher odds of falling, even with adjustment for
drug use and other potential confounding factors
(table 3). The population attributable risk of having
had at least one fall in the previous 12 months,
Table 2 Relation between drug use and falls in previous 12 months in 3742 UK women aged 60-79 years. Values are crude or fully
adjusted* odds ratios (95% confidence interval)
Type of drug
Any falls (n=640) vs no falls (n=3102)
Two or more falls (n=265) vs no falls
(3102)
Falls where medical attention was given
(n=246) vs no falls (n=3102)
Crude Fully adjusted Crude Fully adjusted Crude Fully adjusted
Hypnotics and anxiolytics 1.94 (1.41 to 2.68) 1.41 (1.00 to 1.98) 2.65 (1.76 to 3.98) 1.74 (1.11 to 2.70) 1.28 (0.73 to 2.25) 0.85 (0.46 to 1.57)
Antidepressants 2.02 (1.58 to 2.59) 1.53 (1.15 to 2.02) 2.83 (2.03 to 3.94) 1.89 (1.30 to 2.76) 1.93 (1.33 to 2.80) 1.35 (0.89 to 2.05)
Any central nervous
system drug
1.49 (1.34 to 1.66) 1.25 (1.11 to 1.41) 1.81 (1.57 to 2.08) 1.43 (1.22 to 1.68) 1.48 (1.26 to 1.74) 1.26 (1.05 to 1.52)
Analgesics 1.25 (1.01 to 1.55) 1.00 (0.79 to 1.25) 1.51 (1.14 to 2.00) 1.20 (0.87 to 1.65) 1.08 (0.77 to 1.51) 0.95 (0.66 to 1.36)
Any cardiovascular drug 1.11 (1.04 to 1.18) 0.96 (0.89 to 1.05) 1.24 (1.14 to 1.34) 0.99 (0.88 to 1.11) 1.05 (0.95 to 1.15) 0.90 (0.79 to 1.02)
Any endocrine system
drug
1.13 (0.96 to 1.33) 0.95 (0.77 to 1.18) 1.22 (0.97 to 1.54) 0.80 (0.58 to 1.11) 1.17 (0.92 to 1.50) 1.02 (0.74 to 1.40)
Any respiratory system
drug
1.09 (0.96 to 1.23) 0.91 (0.78 to 1.06) 1.21 (1.03 to 1.42) 1.03 (0.84 to 1.25) 1.13 (0.94 to 1.35) 0.98 (0.79 to 1.21)
*Adjusted for age, body mass index, haemoglobin concentration (continuous variables), circulatory disease, diabetes, thyroid disease, asthma or bronchitis,
depression, cataract or glaucoma, arthritis, heavy alcohol consumption (binary variables), and adult social class (I, II, III non-manual, III manual, IV, V) (indicator
variable).
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estimated from the fully adjusted models, was 6.2%
(2.0% to 10.0%) for coronary heart disease, 6.2% (1.6%
to 10.5%) for circulatory disease, 8.0% (3.3% to 12.4%)
for chronic obstructive pulmonary disease, 9.4% (5.4%
to 13.3%) for depression, and 17.4% (10.4% to 23.9%)
for arthritis. The fully adjusted odds ratio of having had
a fall in the previous 12 months associated with having
at least one of the chronic diseases in table 3 was 1.81
(1.42 to 2.31), and the population attributable risk was
32.2% (19.6% to 42.8%). When we stratified the analy-
ses by the year in which the participant’s disease was
first diagnosed, we found positive associations between
falls and diseases diagnosed before (including up to 10
years before) the year in which the women had a fall.
Effects of combined multiple pathology and
polypharmacy
When number of drugs taken and number of chronic
diseases were included in the same regression model
they combined multiplicatively. The odds ratio for a fall
for each additional chronic disease, adjusted for
number of drugs taken, was 1.39 (1.29 to 1.51), and that
for each additional drug taken, adjusted for number of
chronic diseases, was 1.05 (1.01 to 1.09). There was no
strong evidence of a statistical interaction between
number of drugs and number of chronic diseases
(P = 0.16) and no evidence of statistical interactions
between any of the individual chronic diseases and
their relevant treatment (P > 0.15 for all diseases).
Discussion
The risk of falling rose with the number of drugs taken
and the number of chronic diseases each woman had,
but the association was stronger for multiple pathology
than for polypharmacy and remained in the fully
adjusted analyses. The population attributable risk of
falling associated with having any chronic disease was
much higher (32%) than that associated with use of
psychotropic drugs (between 2% and 5%). Thus in
public health terms targeting prevention and control
of chronic diseases rather than polypharmacy may be a
more useful strategy for preventing falls in elderly
people. Factors commonly supposed to be associated
with falls, such as postural hypotension, alcohol
consumption, and reduced physiological reserve (as
shown by low forced expiratory volume in 1 second)
were not associated with falls in this study.11 12 Contrary
to evidence in previous reviews that risk factors differ
for single falls, frequent falling, and treated falls, we
found similar risk factor profiles for the different types
of fall.13 14
Limitations of the study
Our response rate (60%) is moderate but consistent
with other large contemporary epidemiological sur-
veys.15 As reported previously our respondents were
slightly younger than non-respondents and were less
likely to have a primary care medical record of stroke
or diabetes, although the prevalence of coronary heart
disease and cancer did not vary between respondents
and non-respondents.4 Because chronic diseases are
associated with falling wemay have underestimated the
prevalence of falls. The associations of chronic diseases
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Table 3 Relation between diagnoses of chronic diseases and falls in previous 12 months in 3742 UK women aged 60-79 years.
Values are crude or fully adjusted* odds ratios (95% confidence interval)
Type of drug
Any falls (n=640) v no falls (n=3102)
Two or more falls (n=265) v no falls
(n=3102)
Falls where medical attention was given
(n=246) v no falls (n=3102)
Crude Fully adjusted Crude Fully adjusted Crude Fully adjusted
Coronary heart disease 1.82 (1.47 to 2.25) 1.50 (1.16 to 1.95) 2.83 (2.14 to 3.75) 2.12 (1.49 to 3.03) 1.82 (1.33 to 2.50) 1.64 (1.11 to 2.42)
Any circulatory disease 1.73 (1.42 to 2.12) 1.42 (1.10 to 1.83) 2.63 (2.00 to 3.44) 1.96 (1.39 to 2.77) 1.76 (1.30 to 2.38) 1.56 (1.07 to 2.26)
Diabetes 1.33 (0.93 to 1.90) 1.23 (0.85 to 1.78) 1.49 (0.91 to 2.46) 1.22 (0.69 to 2.15) 1.26 (0.73 to 2.18) 1.07 (0.58 to 1.98)
Thyroid disease 1.30 (1.00 to 1.68) 1.20 (0.90 to 1.61) 1.77 (1.25 to 2.50) 1.70 (1.13 to 2.56) 1.36 (0.92 to 2.00) 1.23 (0.80 to 1.90)
COPD 1.49 (1.24 to 1.80) 1.48 (1.19 to 1.84) 1.51 (1.14 to 1.98) 1.38 (1.00 to 1.90) 1.53 (1.15 to 2.04) 1.51 (1.09 to 2.10)
Depression 2.01 (1.63 to 2.48) 1.76 (1.41 to 2.21) 2.67 (2.01 to 3.56) 2.11 (1.54 to 2.90) 2.45 (1.82 to 3.31) 2.19 (1.58 to 3.02)
Eye disease 1.48 (1.19 to 1.84) 1.22 (0.97 to 1.54) 1.56 (1.14 to 2.13) 1.21 (0.86 to 1.69) 1.41 (1.00 to 1.97) 1.16 (0.81 to 1.65)
Arthritis 1.93 (1.63 to 2.30) 1.60 (1.33 to 1.93) 2.09 (1.62 to 2.70) 1.49 (1.13 to 1.97) 1.72 (1.32 to 2.23) 1.44 (1.08 to 1.91)
*Adjusted for age, body mass index, haemoglobin concentration (continuous variables), circulatory disease, diabetes, thyroid disease, asthma or bronchitis,
depression, cataract or glaucoma, arthritis, and heavy alcohol consumption (binary variables), and adult social class (I, II, III non-manual, III manual, IV, V)
(indicator variable).
COPD=chronic obstructive pulmonary disease.
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and drug use with falling would only be exaggerated if
the associations among non-respondents were in the
opposite direction to the associations among respond-
ers or if they were non-existent, both of which are
unlikely.
Our study is cross sectional and may therefore be
susceptible to reverse causality. With respect to the
effects of antidepressants and hypnotics or anxiolytics,
it is possible that having had a fall may lead to anxiety
or depression and therefore treatment for these condi-
tions. However, assessing the association between drug
use and the prevalence of falling is relevant, because
the plausible mechanism by which central nervous
system drugs result in falls is related to their
contemporary use.16 That there was an association
between falls and number of chronic diseases among
women whose diagnosis had been made before the
year of the fall indicates that these associations are not
due to reverse causality.
We could not assess the effect of all the major
chronic diseases that affect this age group. In particular
we did not collect information on cognitive function.
However, that the participants were able to complete a
detailed health questionnaire suggested that few if any
women had severe dementia. Elderly people may
under-report falls.17 Any such misclassification is likely
to be non-systematic and would therefore dilute the
associations. We used a crude indicator of the severity
of falls: whether the participant had had medical atten-
tion. Although having received medical attention may
indicate a greater severity of fall, it also reflects
sociodemographic and personal factors that influence
the likelihood of getting medical care after a fall.
Implications
As in other studies, our results show an association
between the number of psychotropic drugs taken and
the risk of falling.3 7 Although the population attribut-
able risk of falling associated with these drugs was
small, they may be an important cause of morbidity in
people using them. Trials have shown that gradual
withdrawal of psychotropic drugs is feasible among
elderly people and is associated with a decreased risk
of falling.18
Chronic diseases may increase the risk of falls
through direct effects of the disease and indirect
effects, such as reduced physical activity, muscle weak-
ness, and poor balance. Perhaps because observational
research has focused more on drug use than chronic
diseases, the effect of specific chronic diseases on the
risk of falling has not been the main focus of controlled
trials of interventions to prevent falls, although the
inclusion of exercises specifically aimed at reducing
falls as well as at improving cardiovascular fitness in
cardiac rehabilitation programmes has been recom-
mended.19 Chronic diseases and multiple pathology,
rather than polypharmacy, may be the most important
predictors of falling.
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What is already known on this topic
A number of chronic diseases, use of tranquillisers
and antidepressants, and polypharmacy are
associated with an increased risk of falling,
although the independent associations of
particular diseases and types of drug are unclear
What this study adds
The risk of falling rises with the number of
simultaneous chronic diseases
Elderly women with circulatory diseases, chronic
obstructive pulmonary disease, arthritis, and
depression are at a higher risk of falling, and
chronic diseases may account for 30% of falls in
this group
Anxiolytics, hypnotics, and antidepressants are the
only classes of drugs that are independently
associated with falling
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